Blessing Hospital Outpatient Dermatology

CLIA Laboratory Citation Details

2
Total Citations
8
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 14D2156198
Address 1132 Broadway Street - Ste 200, Quincy, IL, 62301
City Quincy
State IL
Zip Code62301
Phone(217) 214-6250

Citation History (2 surveys)

Survey - September 27, 2024

Survey Type: Standard

Survey Event ID: NMDZ11

Deficiency Tags: D6168 D6171

Summary:

Summary Statement of Deficiencies D6168 TESTING PERSONNEL CFR(s): 493.1487 The laboratory has a sufficient number of individuals who meet the qualification requirements of 493.1489 of this subpart to perform the functions specified in 493. 1495 of this subpart for the volume and complexity of testing performed. This CONDITION is not met as evidenced by: Based on review of laboratory personnel records, interview with testing personnel (TP) #2, and email correspondence with TP #2; the laboratory failed to ensure one of three TP were qualified for high complexity histopathology testing. See D6171. D6171 TESTING PERSONNEL QUALIFICATIONS CFR(s): 493.1489(b) (b) Meet one of the following requirements: (b)(1) Be a doctor of medicine, doctor of osteopathy, or doctor of podiatric medicine licensed to practice medicine, osteopathy, or podiatry in the State in which the laboratory is located or have earned a doctoral, master's or bachelor's degree in a chemical, physical, biological or clinical laboratory science, or medical technology from an accredited institution; (b)(2)(i) Have earned an associate degree in a laboratory science, or medical laboratory technology from an accredited institution or-- (b)(2)(ii) Have education and training equivalent to that specified in paragraph (b)(2)(i) of this section that includes-- (b)(2)(ii)(A) At least 60 semester hours, or equivalent, from an accredited institution that, at a minimum, include either-- (b)(2)(ii)(A)(1) 24 semester hours of medical laboratory technology courses; or (b)(2)(ii)(A)(2) 24 semester hours of science courses that include-- (b)(2) (ii)(A)(2)(i) Six semester hours of chemistry; (b)(2)(ii)(A)(2)(ii) Six semester hours of biology; and (b)(2)(ii)(A)(2)(iii) Twelve semester hours of chemistry, biology, or medical laboratory technology in any combination; and (b)(2)(ii)(B) Have laboratory training that includes either of the following: (b)(2)(ii)(B)(1) Completion of a clinical Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- laboratory training program approved or accredited by the ABHES, the CAHEA, or other organization approved by HHS. (This training may be included in the 60 semester hours listed in paragraph (b)(2)(ii)(A) of this section.) (b)(2)(ii)(B)(2) At least 3 months documented laboratory training in each specialty in which the individual performs high complexity testing. (b)(3) Have previously qualified or could have qualified as a technologist under 493.1491 on or before February 28, 1992; (b) (4) On or before April 24, 1995 be a high school graduate or equivalent and have either-- (b)(4)(i) Graduated from a medical laboratory or clinical laboratory training program approved or accredited by ABHES, CAHEA, or other organization approved by HHS; or (b)(4)(ii) Successfully completed an official U.S. military medical laboratory procedures training course of at least 50 weeks duration and have held the military enlisted occupational specialty of Medical Laboratory Specialist (Laboratory Technician); (b)(5)(i) Until September 1, 1997-- (b)(5)(i)(A) Have earned a high school diploma or equivalent; and (b)(5)(i)(B) Have documentation of training appropriate for the testing performed before analyzing patient specimens. Such training must ensure that the individual has-- (b)(5)(i)(B)(1) The skills required for proper specimen collection, including patient preparation, if applicable, labeling, handling, preservation or fixation, processing or preparation, transportation and storage of specimens; (b)(5)(i)(B)(2) The skills required for implementing all standard laboratory procedures; (b)(5)(i)(B)(3) The skills required for performing each test method and for proper instrument use; (b)(5)(i)(B)(4) The skills required for performing preventive maintenance, troubleshooting, and calibration procedures related to each test performed; (b)(5)(i)(B)(5) A working knowledge of reagent stability and storage; (b)(5)(i)(B)(6) The skills required to implement the quality control policies and procedures of the laboratory; (b)(5)(i)(B)(7) An awareness of the factors that influence test results; and (b)(5)(i)(B)(8) The skills required to assess and verify the validity of patient test results through the evaluation of quality control values before reporting patient test results; and (b)(5)(i)(B)(8)(ii) As of September 1, 1997, be qualified under 493.1489(b)(1), (b)(2), or (b)(4), except for those individuals qualified under paragraph (b)(5)(i) of this section who were performing high complexity testing on or before April 24, 1995; (b)(6) For blood gas analysis-- (b)(6) (i) Be qualified under 493.1489(b)(1), (b)(2), (b)(3), (b)(4), or (b)(5); (b)(6)(ii) Have earned a bachelor's degree in respiratory therapy or cardiovascular technology from an accredited institution; or (b)(6)(iii) Have earned an associate degree related to pulmonary function from an accredited institution; or (b)(7) For histopathology, meet the qualifications of 493.1449 (b) or (l) to perform tissue examinations. This STANDARD is not met as evidenced by: Based on review of laboratory personnel records, interview with testing personnel (TP) #2, and email correspondence with TP #2; the laboratory failed to ensure one of three TP were qualified for high complexity histopathology testing. Findings include: 1. Review of personnel educational documentation revealed one of three TP (TP #2) failed to have qualifying documentation for high complexity histopathology specimen grossing testing prior to reporting test results. 2. On survey date 09/20/2024, at 11:45 am, TP #2 notified the surveyor that they had submitted a request for college transcripts and would email them to the surveyor when they were received. 3. Review of educational transcripts provided by TP #2 via email on 9/27/24, at 7:59 am, found TP #2 failed to meet the education requirements to qualify as a high complexity TP. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - March 13, 2019

Survey Type: Standard

Survey Event ID: 3US711

Deficiency Tags: D5401 D5601 D5781 D5805 D6168 D6171

Summary:

Summary Statement of Deficiencies D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on review of laboratory records and interview with the office manager (OM); the laboratory failed to have a procedure in place to evaluate the method accuracy of Mohs histopathology testing. Findings Include: 1. Review of laboratory's policy and procedure manual found the laboratory failed to have procedures in place to ensure the bi-annual method accuracy of Mohs histopathology testing. 2. On survey date 3- 13-2019, at 1:00 pm, the OM confirmed no procedure was in place to ensure the bi- annual method accuracy of Mohs histopathology testing. D5601 HISTOPATHOLOGY CFR(s): 493.1273(a)(f) (a) As specified in 493.1256(e)(3), fluorescent and immunohistochemical stains must be checked for positive and negative reactivity each time of use. For all other differential or special stains, a control slide of known reactivity must be stained with each patient slide or group of patient slides. Reactions of the control slide with each special stain must be documented. (f) The laboratory must document all control procedures performed, as specified in this section. This STANDARD is not met as evidenced by: Based on review of laboratory records and interview with the office manager (OM); Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 4 -- the laboratory failed to document and perform Hematoxylin and Eosin (H&E) differential staining for 2 of 7 patient testing dates reviewed. Findings Include: 1. Review of the laboratory's policy and procedure manual identified the policy, "Quality Assurance for Routine Stains", which stated: "1. A quality control slide will be run each day the lab operates. 2. The QC (quality control) slide will be for Hematoxylin and Eosin and/or Toliudine blue. Whichever is used in the lab. 3. The QC for the H&E will be of normal skin, have a crisp blue nuclei and light blue to purple counter stain." "The lab director will determine whether the stain is acceptable for the day. Each QC will be logged on the stain QC chart." 2. Review of patient testing for Mohs histopathology found for 2 of 7 patient testing dates reviewed the laboratory failed to have a corresponding H&E quality control slide. Date of Patient Testing 12-18-2018 12-19-2018 3. Review of the "Quality Control Staining" log found no documentation that a quality control slide was performed and determined to be acceptable for 12-18- 2018 and 12-19-2018. 4. Review of patient testing logs found a total of 19 patients who were tested on 12-18-2018 and 12-19-2018 for Mohs histopathology. 5. On survey date 03-13-2019, at 1:00 pm, the OM confirmed no quality control slides were found and no quality control records were documented for differential staining on 12- 18-2018 and 12-19-2018 when Mohs histopathology testing was performed. D5781

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access